-
Mashup Score: 0Thermo Fisher Adds Proteomics to Its Portfolio Through $3.1B Olink Acquisition - MedCity News - 6 month(s) ago
Thermo Fisher Scientific is acquiring Olink, a company that provides proteomics analysis tools and services used in drug discovery research. Olink’s growing revenue will help shore up a Thermo Fisher business segment whose sales have fallen due to declining Covid-19 testing demand.
Source: medcitynews.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
Researchers used Pharma Proteomics Project plasma protein profiles for UK Biobank participants to identify genetic associations with protein levels, providing disease clues.
Source: www.genomeweb.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Genetic Contributors to #PlasmaProtein Levels Unearthed in Multiple Studies @GenomeWeb https://t.co/CjJhw7SWj8 #genomics #proteomics #rarevariants #pQTL
-
-
Mashup Score: 4Rheumatology - 7 month(s) ago
The official journal of the British Society for Rheumatology. Publishes high-quality scientific (basic and translational) and clinical-epidemiological papers on a wide range of paediatric and adult rheumatological and musculoskeletal conditions.
Source: academic.oup.comCategories: Latest Headlines, RheumatologyTweet-
Rheumatology's October issue is now online! Featuring: ⭐ @drdj's choice: Two articles looking at risks with #JAKi 🤖 #AI for #rheumatology 💸 Cost-effectiveness #research 📈 Results from the @BSRBR_RA 📚 Health literacy 🩸 #Proteomics & more https://t.co/Q4zDVUaPX6
-
-
Mashup Score: 1Novel Biomarkers of Necrotizing Enterocolitis in Neonates Undergoing Congenital Heart Disease Surgery: A Pilot Cohort Study - 8 month(s) ago
, University of Colorado‐School of Public Health, , Department of Biostatistics and Informatics, , Aurora, , CO, , USA, *Correspondence to: Jesse Davidson, MD, Children’s Hospital Colorado, 13123 E 16th Ave, ‐Box 100, Aurora, CO 80045. Email: Congenital heart disease (CHD) is a risk factor for the development of necrotizing enterocolitis (NEC). 1 NEC has an incidence of 3% to 5% in the population with CHD and is associated with a 2‐fold increase in mortality (24.4% versus 11.8% in neonates with CHD
Source: www.ahajournals.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Pilot study from @ChildrensColo demonstrates power of novel low volume #proteomics techniques to safely perform #biomarker discovery in neonates w/ #CHD & necrotizing enterocolitis. #AHAJournals #ResearchLetter @ChildrensCO_Pro @OlinkProteomics @JesseCicu https://t.co/WcTtk70VJU https://t.co/isltoVNWze
-
-
Mashup Score: 1Reducing reductionism: addressing risk for atherosclerotic cardiovascular disease by apolipoprotein proteomics - 9 month(s) ago
For decades, strategies aimed at predicting and preventing atherosclerotic cardiovascular disease (ASCVD) have rightly focused on low-density lipoprotein choles
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
Reducing reductionism: addressing risk for #ASCVD by apolipoprotein #proteomics https://t.co/j121WoXRZq
-
-
Mashup Score: 2The proteomic landscape of soft tissue sarcomas - Nature Communications - 10 month(s) ago
Characterising the molecular profile of soft tissue sarcomas (STS) remains critical. Here, the authors analyse samples from 321 STS patients across 11 histological subtypes using proteomics and identify prognostic signatures that can be applied to multiple subtypes.
Source: NatureCategories: General Medicine News, Latest HeadlinesTweet-
Authors from @HuangLabICR analyse samples from 321 soft tissue #sarcoma patients across 11 subtypes using #proteomics and find prognostic signatures #CancerResearch @NatResCancer https://t.co/CLjrkroQBG
-
-
Mashup Score: 0Higher Scientific Officer - Proteomics (ID 631) in Sutton (Greater London) | The Institute of Cancer Research - 10 month(s) ago
View details and apply for this Higher Scientific Officer – Proteomics (ID 631) vacancy in Sutton (Greater London). Salary : Commencement on the salary range is subject to comparable skills and experience. Future progression is based on annual performance review. This role is eligible for ICR S…
Source: The Institute of Cancer ResearchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🚨Last few days to apply for the role of Higher Scientific Officer in #Proteomics analysis of #Sarcoma and #BreastCancer. If you have experience in mass spectrometry-based proteomics, please apply to join @HuangLabICR. 🔵Deadline: 30 June. https://t.co/jp5h83Y0z0
-
-
Mashup Score: 4
Welcome! You are invited to join a webinar: Frontiers in Cardiovascular Science Seminar. After registering, you will receive a confirmation email about joining the webinar.
Source: ZoomCategories: Cardiologists, Latest HeadlinesTweet-
Please join @StanfordCVI on Tue 6/20 at 12-1pm PST by @AliciaLundby @BiomedUCPH @CopCard speak on quantitative #proteomics in #cardiovasculardiseases Zoom link: https://t.co/oD1xyw8xBX @StanfordDeptMed @Stanford_ChEMH @HFSA @SeanM_Wu @vascularbiology @asmsnews @molcellprot https://t.co/5UiSEhNKCm
-
-
Mashup Score: 0Higher Scientific Officer - Proteomics (ID 631) in Sutton (Greater London) | The Institute of Cancer Research - 11 month(s) ago
View details and apply for this Higher Scientific Officer – Proteomics (ID 631) vacancy in Sutton (Greater London). Salary : Commencement on the salary range is subject to comparable skills and experience. Future progression is based on annual performance review. This role is eligible for ICR S…
Source: The Institute of Cancer ResearchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🚨 @HuangLabICR is recruiting a new team member to work on #Proteomics analysis of clinical specimens. If you'd like to contribute to our world-class #CancerResearch and have experience in mass spectrometry-based proteomics, check this out and apply⬇️ https://t.co/jp5h83Y0z0
-
-
Mashup Score: 1Cancer cells shrink or super-size to survive - 12 month(s) ago
Cancer cells can shrink or super-size themselves to survive drug treatment or other challenges within their environment, researchers have discovered.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
ICR scientists (@BakalLabICR) used image analysis and #Proteomics to reveal how genetic changes lead to differences in the size of #Melanoma #SkinCancer cells – and how these changes could be exploited by new treatments. #SkinCancerAwarenessMonth https://t.co/V2OCXunf8u
-
Thermo Fisher Adds #Proteomics to Its Portfolio Through $3.1B #Olink Acquisition https://t.co/adqCg8RUF0